The Effect of Omega-3 Supplementation on Heart Failure Outcome: A Meta-Analysis of Randomized Clinical Trial
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The effect of omega-3 supplementation on cardiovascular (CV) disease has been widely studied in several large clinical trials. However, the evidence of the effect of omega-3 supplementation in patients with heart failure (HF) remains controversial. This meta-analysis investigated the effects of omega-3 supplementation on patients with HF. We conducted a literature search on MEDLINE, Embase, and Cochrane databases for clinical trials and preprints of relevant articles. Following a literature search and critical appraisal, 5 studies were included in the meta-analysis. The pooling of the result of the studies shows that there were no significant association between omega-3 supplementation and CV mortality (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.84–1.05, p=0.16) nor hospitalization due to HF (OR, 0.94; 95% CI, 0.88–1.02; p=0.13). Our systematic review and meta-analysis showed that omega-3 supplementation has no beneficial effect in patients with HF.
Abstract
The effect of omega-3 supplementation on cardiovascular (CV) disease has been widely studied in several large clinical trials. However, the evidence of the effect of omega-3 supplementation in patients with heart failure (HF) remains controversial. This meta-analysis investigated the effects of omega-3 supplementation on patients with HF. We conducted a literature search on MEDLINE, Embase, and Cochrane databases for clinical trials and preprints of relevant articles. Following a literature search and critical appraisal, 5 studies were included in the meta-analysis. The pooling of the result of the studies shows that there were no significant association between omega-3 supplementation and CV mortality (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.84–1.05, p=0.16) nor hospitalization due to HF (OR, 0.94; 95% CI, 0.88–1.02; p=0.13). Our systematic review and meta-analysis showed that omega-3 supplementation has no beneficial effect in patients with HF.
참고문헌 (17)
- O’Keefe JH Jr, "From Inuit to implementation : omega-3 fatty acids come of age", Mayo Clin Proc, 75, pp.607~614 (2000)
- Bhatt DL, "Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia", N Engl J Med, 380, pp.11~22 (2019)
- Risk and Prevention Study Collaborative Group, "n-3 fatty acids in patients with multiple cardiovascular risk factors", N Engl J Med, 368, pp.1800~1808 (2013)
- Djoussé L, "Supplementation with vitamin D and omega-3 fatty acids and incidence of heart failure hospitalization : VITAL-Heart Failure", Circulation, 141, pp.784~786 (2020)
- Mehra MR, "Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure", J Heart Lung Transplant, 25, pp.834~838 (2006)
- Kohashi K, "Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia", J Atheroscler Thromb, 21, pp.712~729 (2014)
- Kalstad AA, "Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction : a randomized, controlled trial", Circulation, 143, pp.528~539 (2021)
- ORIGIN Trial Investigators, "n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia", N Engl J Med, 367, pp.309~318 (2012)
- Tavazzi L, "Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure(the GISSI-HF trial) : a randomised, double-blind, placebo-controlled trial", Lancet, 372, pp.1223~1230 (2008)
- Nodari S, "Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy", J Am Coll Cardiol, 57, pp.870~879 (2011)
- Kojuri J, "Effect of omega-3 on brain natriuretic peptide and echocardiographic findings in heart failure : double-blind placebo-controlled randomized trial", J Cardiovasc Dis Res, 4, pp.20~24 (2013)
- Welty FK, "How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?", Curr Cardiol Rep, 15, pp.400~ (2013)
- Greene SJ, "Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction(from the EVEREST Trial)", Am J Cardiol, 111, pp.574~581 (2013)
- Tribulova N, "Omega-3 index and anti-arrhythmic potential of omega-3 PUFAs", Nutrients, 9, pp.1191~ (2017)
- Wang C, "The role of omega-3 polyunsaturated fatty acids in heart failure : a meta-analysis of randomised controlled trials", Nutrients, 9, pp.18~ (2016)
- Linssen GC, "N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population", Eur Heart J, 31, pp.120~127 (2010)
- Barbarawi M, "Omega-3 supplementation and heart failure : a meta-analysis of 12 trials including 81, 364 participants", Contemp Clin Trials, 107, pp.106458~ (2021)